Omnitram Pharmacokinetic and Analgesic Study Following CY2D6 Inhibition With Paroxetine In Healthy Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03312777

Recruitment Status : Completed

First Posted : October 18, 2017

Last Update Posted : December 28, 2017

View this study on Beta.ClinicalTrials.gov

Sponsor:

Collaborators:

PRA Health Sciences

DF/Net Rearch

ITT Research Institute

Information provided by (Responsible Party):

Syntrix Biosystems, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	December 15, 2017
Actual Study Completion Date :	December 22, 2017

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Zebala JA, Searle SL, Webster LR, Johnson MS, Schuler AD, Maeda DY, Kahn SJ. Desmetramadol Has the Safety and Analgesic Profile of Tramadol Without Its Metabolic Liabilities: Consecutive Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Trials. J Pain. 2019 Oct;20(10):1218-1235. doi: 10.1016/j.jpain.2019.04.005. Epub 2019 Apr 18.

To Top